Cargando…
CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) remains the most common malignant cancer worldwide. Numerous studies have indicated that C-type lectin domain family 4 member M (CLEC4M) is associated with tumor progression; however, the biological functions of CLEC4M in HCC have not been investigated. In the present...
Autores principales: | Yu, Qianle, Gao, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411413/ https://www.ncbi.nlm.nih.gov/pubmed/32705212 http://dx.doi.org/10.3892/mmr.2020.11336 |
Ejemplares similares
-
High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020) -
Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma
por: Guo, Rui-Ming, et al.
Publicado: (2018) -
CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021) -
High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
por: Yin, Chengliang, et al.
Publicado: (2021) -
Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
por: Ni, Jun, et al.
Publicado: (2018)